文献速递肿瘤 PET/CT

基于18F-FDG PET/CT预测肺腺癌患者胸腔积液性质

Predicting the nature of pleural effusion in patients with lung adenocarcinoma based on 18F-FDG PET/CT.
PubMed 文献 · EJNMMI Res · 2021-10-15

本研究纳入413例肺腺癌伴胸腔积液患者,利用训练队列的PET/CT参数和临床信息建立预测恶性胸腔积液的列线图模型,并在测试队列验证。模型在训练队列AUC为0.970(95%CI 0.954-0.986),测试队列AUC为0.979(95%CI 0.961-0.998),校准良好,决策曲线分析显示临床有用。

要点

  • CEA、肿瘤SUVmax、胸膜附着、阻塞性肺不张或肺炎、胸膜SUVmax、胸腔积液SUVmax为恶性胸腔积液独立预测因素。
  • 基于上述因素构建的列线图模型在训练队列和测试队列均显示良好区分度和校准度。
  • 决策曲线分析表明该列线图具有临床实用性,有助于鉴别恶性与良性胸腔积液。

核心结论

  • 基于18F-FDG PET/CT的预测模型对肺腺癌患者胸腔积液性质具有良好诊断性能,有助于鉴别恶性胸腔积液与良性胸腔积液。

研究设计与样本

  • 回顾性收集413例接受18F-FDG PET/CT的肺腺癌伴胸腔积液患者,分为训练队列289例和测试队列124例。
  • 在训练队列中收集PET/CT参数和临床信息,筛选恶性胸腔积液的独立预测因素并建立预测模型,以列线图呈现。
  • 将模型应用于测试队列评估诊断效能。

主要发现

  • 413例患者中恶性胸腔积液245例,良性胸腔积液168例。
  • CEA、肿瘤SUVmax、胸膜附着、阻塞性肺不张或肺炎、胸膜SUVmax、胸腔积液SUVmax被确定为恶性胸腔积液的独立显著因素。
  • 预测模型在训练队列AUC为0.970(95%CI 0.954-0.986),校准良好。
  • 列线图在测试队列AUC为0.979(95%CI 0.961-0.998),校准良好。
  • 决策曲线分析证明该列线图具有临床实用性。

临床怎么用

  • 可利用基于18F-FDG PET/CT参数和临床信息构建的列线图辅助鉴别肺腺癌患者的恶性与良性胸腔积液。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study aims to establish a predictive model on the basis of 18F-FDG PET/CT for diagnosing the nature of pleural effusion (PE) in patients with lung adenocarcinoma. METHODS: Lung adenocarcinoma patients with PE who underwent 18F-FDG PET/CT were collected and divided into training and test cohorts. PET/CT parameters and clinical information in the training cohort were collected to estimate the independent predictive factors of malignant pleural effusion (MPE) and to establish a predictive model. This model was then applied to the test cohort to evaluate the diagnostic efficacy. RESULTS: A total of 413 lung adenocarcinoma patients with PE were enrolled in this study, including 245 patients with MPE and 168 patients with benign PE (BPE). The patients were divided into training (289 patients) and test (124 patients) cohorts. CEA, SUVmax of tumor and attachment to the pleura, obstructive atelectasis or pneumonia, SUVmax of pleura, and SUVmax of PE were identified as independent significant factors of MPE and were used to construct a predictive model, which was graphically represented as a nomogram. This predictive model showed good discrimination with the area under the curve (AUC) of 0.970 (95% CI 0.954-0.986) and good calibration. Application of the nomogram in the test cohort still gave good discrimination with AUC of 0.979 (95% CI 0.961-0.998) and good calibration. Decision curve analysis demonstrated that this nomogram was clinically useful. CONCLUSIONS: Our predictive model based on 18F-FDG PET/CT showed good diagnostic performance for PE, which was helpful to differentiate MPE from BPE in patients with lung adenocarcinoma.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Li Y, Mu W, Li Y, et al. Predicting the nature of pleural effusion in patients with lung adenocarcinoma based on 18F-FDG PET/CT. EJNMMI Res. 2021. PMID: 34652524. doi:10.1186/s13550-021-00850-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。